Search - tctmd.com

Displaying 41 - 50 of 50

Sort: Relevancy | Date

Poll: Revascularization or Medical Therapy?

Presentation THT 2023

Poll: Revascularization or Medical Therapy?

Presenter: Dor Lotan

March 20, 2023

Assessing the Residual Risk: What Gaps Should New Technologies Fill?

Presentation THT 2023

Assessing the Residual Risk: What Gaps Should New Technologies Fill?

Presenter: Javed Butler

March 20, 2023

The AI Revolution and How It Is Impacting Health Care Delivery in Heart Failure

Presentation THT 2023

The AI Revolution and How It Is Impacting Health Care Delivery in Heart Failure

Presenter: Nir Uriel

March 20, 2023

Recent Advances in the Medical Treatment of Patients With Decompensated Heart Failure

Presentation THT 2023

Recent Advances in the Medical Treatment of Patients With Decompensated Heart Failure

Presenter: Alexandre Mebazaa

March 20, 2023

Contemporary Implementation of Guideline-Directed Therapy for Heart Failure

Presentation THT 2023

Contemporary Implementation of Guideline-Directed Therapy for Heart Failure

Presenter: Gad Cotter

March 20, 2023

SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits

Presentation THT 2023

SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits

Presenter: Milton Packer

March 20, 2023

The Impact of SGLT2 Inhibitors Across the Spectrum of Heart Failure

Presentation THT 2023

The Impact of SGLT2 Inhibitors Across the Spectrum of Heart Failure

Presenter: Scott Solomon

March 20, 2023

Opening Talk: Innovation and Technologies to Enhance the Care of Patients With Heart Failure

Presentation THT 2023

Opening Talk: Innovation and Technologies to Enhance the Care of Patients With Heart Failure

Presenter: Daniel Burkhoff

March 20, 2023

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

February 07, 2022

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Presentation THT 2022

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Presenter: Barry Greenberg

February 01, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.